BIOA vs AMPH

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

BIOA

48.6
AI Score
VS
AMPH Wins

AMPH

50.6
AI Score

Investment Advisor Scores

BIOA

49score
Recommendation
HOLD

AMPH

51score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric BIOA AMPH Winner
Forward P/E 0 0 Tie
PEG Ratio 0 2.77 Tie
Revenue Growth 1.6% 5.4% AMPH
Earnings Growth 0.0% 4.7% AMPH
Tradestie Score 48.6/100 50.6/100 AMPH
Profit Margin 0.0% 10.8% AMPH
Beta 1.00 1.00 Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

BIOA 1M: -30.3% · 3M: -74.7% AMPH 1M: +4.7% · 3M: +39.6%

Current Technical Phase

BIOA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -35.7%), weak momentum, RSI 31

RSI (14): 30.9 · Price: $5.50

AMPH

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (11.4% over 20 days), RSI 57

RSI (14): 57.4 · Price: $26.14

Fundamentals Snapshot

Metric BIOA AMPH
Market Cap — —
Forward P/E -2.2 9.9
Trailing P/E — 15.5
Revenue (TTM) — —
Revenue Growth 0.0% 0.1%
Gross Margin -7.5% 0.5%
Operating Margin -12.0% 0.2%
EPS -2.39 1.69
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, AMPH is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.